Peripheric and automatic neuropathy in children with type 1 diabetes mellitus: The effect of L-carnitine treatment on the peripheral and autonomic nervous system

Electromyography and Clinical Neurophysiology

Volumn 45, Issue 6, 2005, Pages 343-351

  Uzun, Nurten ^a   Sarikaya, Sevil ^a   Uluduz, Derya ^a,b   Aydin, Ahmet ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

^b Pediatrics Department ^*  (Turkey)

Author keywords

Carnitine; Electrodiagnostic studies; Type I diabetic neuropathy

Indexed keywords

CARNITINE;

ADRENERGIC ACTIVITY; ARTICLE; AUTONOMIC NERVOUS SYSTEM; AUTONOMIC NEUROPATHY; CHILD; CHILDHOOD DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETIC NEUROPATHY; DRUG DOSE REGIMEN; DRUG EFFICACY; ELECTROMYOGRAPHY; FEMALE; FREQUENCY ANALYSIS; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; NERVE CONDUCTION; NERVOUS SYSTEM ELECTROPHYSIOLOGY; NERVOUS SYSTEM PARAMETERS; NEUROLOGIC DISEASE; NEUROLOGIC EXAMINATION; NEUROPATHOLOGY; PERIPHERAL NERVOUS SYSTEM; PERIPHERAL NEUROPATHY; SKIN FUNCTION;

ADOLESCENT; ADULT; AUTONOMIC NERVOUS SYSTEM; CARNITINE; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; DIABETIC NEUROPATHIES; ELECTROPHYSIOLOGY; FEMALE; HUMANS; MALE; NEURAL CONDUCTION; PERIPHERAL NERVOUS SYSTEM; PROSPECTIVE STUDIES; VITAMIN B COMPLEX;

EID: 27944511506     PISSN: 0301150X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Akbar, D.H., Mira, S.A., Zawawi, T.H. and Malibary, H.M.: Subclinical diabetic neuropathy: a common complication in Saudi diabetics. Saudi Med J., 21(5): 433-7, 2000.
2. Arduini, A., Chiodi, P., Bellucci, A. and Calvani, M.: Abnormality of nerve conduction in diabetic neuropathy: Is there a functional relationship with the carnitine system? Neurology., 46(3): 851, 1996.
3. Cejka, J. and Kithier, K.: Serum carnitine quantification. Clin Chem., 38(2): 304-5, 1992.
4. Cenesiz, F., Tur, B.S., Tezic, T., Gurer, Y: Nerve conduction in children suffering insulin-dependent diabetes mellitus. Indian J Pediatr., 70(12): 945-51, 2003.
5. Trotta, D., Verrotti, A., Salladini, C. and Chiarelli, F.: Diabetic neuropathy in children and adolescents.
6. De Grandis, D. and Minardi, C.: Acetyl-L-carnitine (levacecarnine) in the treatment of diabetic neuropathy. A longterm, randomised, double-blind, placebo-controlled study. Drugs R D., 3(4): 223-31, 2002.
7. De Liza, J.A.: Manual of nerve conduction velocity and clinical neurophysiology. 3th Raven Press New York, p. 189, 1994.
8. Deuschl, G. and Eisen, A.: Recommendations for the practice of clinical neurophysiological guidelines of the international federation of clinical neurophysiology. Electroenceph. Clin. Neurophy., 2nd edition Suppl 52, 1999.
9. Diabetes Control and Complications Trial Research Group.: The effect of intensive diabetes therapy on the development and progression of neuropathy. Ann Intern Med, 122(8): 561-8, 1995.
10. Dyck, P.J., Karnes, J. and O'Brien, P.C.: Diagnosis staging and classification of diabetic neuropathy and associations with other complications. In: Dyck, P.J., Thomas, P.K., Winegrad, A.L.(Ed), Diabetic neuropathy, pp. 36-45, WB Saunders, Philadelphia, 1987.
11. Greene, D.A. and Lattimer, S.A.: Action of sorbinil in diabetic peripheral nerve. Relationship of polyol (sorbitol) pathway inhibition to a myo-inositol-mediated defect in sodium-potassium ATP-ase activity. Diabetes, 33(8): 712-6, 1984.
12. Greene, D.A., Lattimer-Greene, S. and Sima, A.A.: Pathogenesis of diabetic neuropathy: role of altered phosphoinositide metabolism. C Rev Neurobiol., 5: 143-219, 1989.
13. Hoffman, W.H., Hart, Z.H. and Frank, R.N.: Correlates of delayed motor nerve conduction and retinopathy in juvenile-onset diabetes mellitus. J Pediatr., 102(3): 351-6, 1983.
14. Huang, Y.N., Jia, Z.R., Shi, X. and Sun, X.R.: Value of sympathetic skin response test in the early diagnosis of diabetic neuropathy. Chin Med J (Engl)., 117(9): 1317-20, 2004.
15. Ido, Y, McHowat, J., Chang, K.C., Arrigoni-Martelli, E., Orfalian, Z., Kilo, C., Corr, P.B. and Williamson, J.R.: Neural dysfunction and metabolic imbalances in diabetic rats. Prevention by acetyl-L-carnitine. Diabetes, 43(12): 1469-77, 1994..
16. karsidag, S., Morali, S., Sargin, M., Salman, S., Karsidag, K. and Us, O.: The electrophysiological findings of subclinical neuropathy in patients with recently diagnosed type 1 diabetes mellitus. Diabetes Res Clin Pract., 67(3): 211-9, 2005
17. kaar, M.L., Saukkonen, A.L., Pitkanen, M., Akerblom, H.K.: Peripheral neuropathy in diabetic children and adolescents. A cross-sectional study. Acta Paediatr Scand., 72(3): 373-8, 1983.
18. Larsen, J.R., Sjoholm, H., Hanssen, K.F., Sandvik, L., Berg, T.J. and Dahl-Jorgensen, K.: Optimal blood glucose control during 18 years preserves peripheral nerve function in patients with 30 years' duration of type 1 diabetes. Diabetes Care., 26(8): 2400-4, 2003.
19. Malone, J.I., Lowitt, S., Salem, A.F., Miranda, C., Korthals, J.K. and Carver, J.: The effects of acetyl-L-carnitine and sorbinil on peripheral nerve structure, chemistry, and function in experimental diabetes. Metabolism., 45(7): 902-7, 1996.
20. Okuda, Y, Kawai, K., Murayama, Y. and Yamashita, K.: Postprandial changes in plasma ketone body and carnitine levels in normal and non-insulin-dependent diabetic subjects. Endocrinol Jpn., 34(3): 415-22, 1987.
21. Ozge, A., Saracoglu, M., Gurtekin, Y., Erenoglu, N.Y. and Akyatan, M.N.: The sensitivity of sympathetic skin responses and standard electrophysiological methods in the diagnosis of diabetic neuropathy. Electromyogr. Clin. Neurophysiol., 40(1): 37-43, 2000.
22. Pearson, D.J. and Tubbs, P.K.: Carnitine and derivates in rat tissues. Biochem J., 105: 953-63, 1967.
23. Scriver, C.R., Beaudet, A.L., Sly, W.S. and Valle, D.: The metabolic bases of inherited diseases. Mac Graw. 8th edition, 2001.
24. Sima, A.A., Prashar, A., Zhang, W.X, Chakrabarti, S. and Greene, D.A.: Preventive effect of long-term aldose reductase inhibition (ponalrestat) on nerve conduction and sural nerve structure in the spontaneously diabetic Bio-Breeding rat. J Clin Invest., 85(5): 1410-20, 1990.
25. Sima, A.A., Ristic, H., Merry, A., Kamijo, M., Lattimer, S.A., Stevens, M.J. and Greene, D.A.: Primary preventive and secondary interventionary effects of acetyl-L-carnitine on diabetic neuropathy in the bio-breeding Worcester rat. J Clin Invest., 15; 97(8): 1900-7, 1996.
26. Sima, A.A., Calvani, M., Mehra, M. and Amato, A.: Acetyl-L-carnitine improves pain, nerve regeneration, and vibratory perception in patients with chronic diabetic neuropathy: an analysis of two randomised placebo-controlled trials. Diabetes Care., 28(1): 89-94, 2005.
27. Sosenko, J.M., Boulton, A.J., Kubrusly, D.B., Wein-Traub, J.K. and Skyler, J.S.: The vibratory perception threshold in young diabetic patients: associations with glycemia and puberty. Diabetes Care, 8(6): 605-7, 1985.
28. Winegrad, A.L.: Banting lecture 1986. Does a common mechanism induce the diverse complications of diabetes? Diabetes., 36(3): 396-406, 1987.
29. Winter, S.C., Simon, M., Zorn, E.M., Szabo-Aczel, S., Vance, W.H., O'Hara, T. and Higashi, L.: Relative carnitine insufficiency in children with type 1 diabetes mellitus. Am J Dis Child., 143(11): 1337-9, 1989.